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Historically, chemists’ exploration of chemical space has been exceptionally uneven and unsystematic. 
This feature article outlines a comprehensive conceptual framework that may be used to capture, analyse 
and plan synthetic approaches that may address this historically uneven exploration.  Illustrative examples 
of synthetic approaches that target, or have potential to target, broad tracts of lead-like chemical space are 
presented within the context of this conceptual framework.   Particular emphasis is placed on synthetic 10 
approaches that enable the combinatorial variation of molecular scaffold, particularly within the 
boundaries of lead-like chemical space. 
Introduction 
The discovery of bioactive small molecules has been shaped, in 
large part, by the historic exploration of chemical space by 15 
chemical synthesis (and biosynthesis).  The scaffolds of known 
bioactive small molecules, in particular, play a key role in 
guiding chemists’ navigation of biologically-relevant chemical 
space.1,2 Vast sources of historic structure–activity relationship 
data have allowed the chemical space defined by known bioactive 20 
ligands to be mapped.3 The field of biology-oriented synthesis 
(BIOS),4 for example, seeks to focus on biologically-relevant 
chemical space by using biologically-validated scaffolds5,6,7 to 
inspire library design. 
25 
 
Figure Scaffold diversity of the organic chemistry universe.8  The 24 282 
284 cyclic compounds in the CAS registry in 2008 are grouped from the 
most popular 5% to the least popular 5% of scaffolds.  Around half of the 
known compounds are based on just 0.25% of known molecular 30 
scaffolds!   
Worryingly, however, chemists’ historical exploration of 
chemical space has been exceptionally uneven and unsystematic. 
Around half of all known compounds are based on just 0.25% of 
the known molecular scaffolds (Figure)!8,
‡
 This uneven 35 
exploration is also reflected in small molecule screening 
collections:6,9 consequently, the biological properties of small 
molecules have not been annotated systematically, with huge 
emphasis on a small number of synthetically accessible scaffolds. 
To what extent, then, are our collective views about the biological 40 
relevance of chemical space skewed by our uneven exploration 
by synthesis? 
 
In this article, we describe synthetic approaches that have 
emerged recently to allow chemical space to be explored more 45 
systematically.  We introduce a conceptual framework that allows 
these valuable approaches to be analysed, compared and 
extended.  We have emphasised approaches that allow significant 
variation of the molecular scaffold prepared.  In contrast to our 
previous review of diversity-oriented synthetic approaches,10 we 50 
focus here on approaches that facilitate exploration within the 
boundaries of lead-like chemical space.  Thus in each case, the 
approaches highlighted may yield products that could be 
decorated to give large numbers of lead-like small molecules. 
Lead-like chemical space   55 
There is a strong link between the molecular properties of clinical 
candidates, and the probability of their successful negotiation of 
the development process to yield marketed drugs.11  Molecular 
properties that have been shown to correlate with success in the 
development process include molecular size and lipophilicity 60 
(clogP),12 the number of aromatic rings13 (nAr) and the fraction 
of sp3-hybridised carbons (Fsp3).14 The optimisation process 
almost inevitably increases both molecular weight and 
lipophilicity, making it essential to control the properties of initial 
leads.15,16  The concept of lead-oriented synthesis has recently 65 
been introduced to highlight specific challenges associates with 
preparing lead-like small molecules i.e. molecules that would be 
good starting points for lead optimisation (see Table 1).17  
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Table 1 Preferred molecular properties and features that have been 
proposed for lead-like small molecules17 
Molecular property/feature Preferred values 
  
Lipophilicity -1 < clogP < 3 
Molecular size 14  heavy atoms  26a 
Aromatic rings nAr  3 
Shape More 3D shapeb 
Sub-structures Absence of chemically-reactive, 
electrophilic or redox-active groups 
aMolecular weight, MR, ~200-350.  
bThe fraction of sp3 carbons (Fsp3) can 
be a useful parameter for assessing three dimensionality.14 5 
 
A recent survey17 showed that the vast majority (>99%) of 
commercially-available screening compounds do not have lead-
like properties. ¶  Furthermore, most compounds (~98%) reported 
in recent synthetic methodology papers are also not lead-like.║ 10 
This problem may stem, in part, from the rather narrow toolkit of 
reactions that is widely used to support drug discovery.18,19  
Although diversity-oriented approaches10,20,21,22  have emerged to 
allow the variation of molecular scaffold, these approaches have 
tended to yield small molecules that lie well outside lead-like 15 
chemical space.  The development of robust methodology for 
preparing large numbers of lead-like molecules for screening thus 
remains a significant and largely unmet challenge.     
A comprehensive conceptual framework  
Some frameworks have been developed to describe alternative 20 
synthetic approaches to diverse molecular scaffolds.  For 
example, the “build–couple–pair”20,** framework is broad, and 
has been used to describe synthetic approaches in which building 
blocks are combined to yield alternative molecular scaffolds.  
Ambiphile pairing reactions23 (in which pairs of bifunctional 25 
building blocks are combined to yield scaffolds) may be 
considered to be a subset of reactions that exemplify the “build-
couple-pair” approach.  
 
Here, we describe a comprehensive conceptual framework that 30 
classifies synthetic approaches that convert building blocks into 
diverse small molecule scaffolds (often in more than one step).  
The framework is hierarchical, and therefore captures the relative 
power of different approaches.  Synthetic approaches to 
molecular scaffolds are more powerful if more bonds are formed 35 
to individual building blocks, or if more building blocks are used.  
 
Synthetic approaches are classified according to the number of 
new bonds formed to each of the building blocks in the 
conversion into molecular scaffolds; new bonds between 40 
functional groups within a building block are counted only once.  
Illustrative examples of three approaches to molecular scaffolds 
are shown in Scheme 1.††  For example, the aminoarylation 
reaction to give the pyrrolidine 3 involves cyclisation of the (bi-
connective) pentenamine derivative 1 with concomitant arylation 45 
(with the uni-connective aryl bromide 2) (Panel A);24 the 
aminoarylation reaction 1 + 2  3 is thus classified as a bi/uni 
process.  An ambiphile pairing reaction (4 + 5) leading to the 
formation of a cyclic sultam (6) is shown in Panel B:23 here, both 
of the building blocks are bi-connective, and so the overall 50 
approach is classified as a bi/bi process.  The formation of the 
bridged bicyclic scaffold 11 is even more powerful because three 
building blocks are used, and three bonds are formed to two of 
these building blocks;25 the approach exploits two tri-connective 
(7 and 8) and one bi-connective (9) building block, and thus 55 
receives the tri/tri/bi classification. 
 
 
Scheme 1 Overview of our conceptual framework for classifying 
synthetic approaches to molecular scaffolds.  The framework classifies 60 
the number of new bonds to each of the building block in the conversion 
into a molecular scaffold.  Illustrative examples of three approaches to 
molecular scaffolds are provided: the application of an aminoarylation in 
the synthesis of pyrrolidines (Panel A), an ambiphile pairing reaction in 
the synthesis of cyclic sultams (Panel B), and a reaction sequence leading 65 
to bridged bicyclic scaffolds (Panel C).  In each case, colour is used to 
show the correspondence between building block and substructures in 
intermediates and products; new connections between and within building 
blocks are shown in black. 
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Scheme 2 The classification describes the overall conversion of building 
blocks into molecular scaffolds.  The classification of synthetic 
approaches thus depends on the building blocks that are exploited 
(compare Panels A and B).  In this review, we consider that it should be 5 
possible to vary independently all of the building blocks used in a 
synthetic approach; thus, unless variation of the alkenyl building block in 
the illustrated aminoarylation reaction is possible (shown explicitly in 
Panel B), it would be appropriate to classify the reaction as a bi/uni 
process (Panel A). 10 
It is important to note that the classification describes the overall 
conversion of building blocks into molecular scaffolds.  Thus, the 
classification depends on the specific building blocks that are 
considered to be starting materials (and not just the product 
scaffold).  This classification thus captures the increased 15 
molecular complexity of the product scaffold relative to the 
starting building blocks.  In this review, we consider that it 
should be possible to vary independently all of the building 
blocks.  For this reason, the synthesis of the morpholine 14 
(Scheme 2) is probably best classified as a bi/uni process (12 + 13 20 
 14, Panel A) because the component 16, allyl bromide, (Panel 
B) was not varied.  Ultimately, the value of specific synthetic 
approaches will depend on the accessibility of the starting 
materials, the increased molecular complexity of the product 
scaffolds, the diversity of the product scaffolds, and the 25 
molecular properties of  the derivatives that may be prepared. 
Approaches to the synthesis of lead-like scaffolds 
This article focuses on synthetic approaches that may allow lead-
like chemical space to be explored more systematically.  A 
central challenge in this area is to develop synthetic approaches 30 
that allow variation of molecular scaffold within the boundaries 
of lead-like chemical space.  Many reactions are systematically 
less successful with more polar building blocks,17 and few 
reactions have been retooled to allow lead-like chemical space to 
be targeted more effectively.26  This article focuses, therefore, on 35 
illustrative approaches that have emerged that allow (or have 
potential to allow) control over the scaffold of lead-like small 
molecules; it is not a comprehensive review of these approaches.  
The approaches are organised according to the conceptual 
framework that we have developed to classify, capture and extend 40 
approaches to the synthesis of diverse molecular scaffolds.   
Approaches involving a bi- and a uni-connective building 
block  
The simplest class of transformation highlighted in this article 
exploits reactions between a bi- and a uni-connective building 45 
block.  We have deliberately not focused on cyclisations of a 
single uni-connective building block (which cannot allow 
combinatorial variation of the product scaffold) or reactions 
between two uni-connective building blocks (which are simply 
cross-coupling reactions).  50 
 
Scheme 3 Application of aminoarylation reactions in the synthesis of 
heterocyclic scaffolds.  Panel A: Illustrative example of the approach in 
the synthesis of a piperazine.  Panel B: Examples of other piperazines that 
may be prepared using the approach described in Panel A.  Panel C: 55 
Examples of other heterocycles to which the general approach has been 
applied. 
Aminoarylation reactions have been exploited in the synthesis of 
a wide range of heterocyclic scaffolds (Scheme 3).  For example, 
Pd-catalysed cyclisation of (bi-connective) unsaturated amine 60 
derivatives (e.g. 17), with concomitant arylation, enables the 
synthesis of piperazines (e.g. 19-22), generally with high 
diastereoselectivity (Panels A and B).27  Under related reaction 
conditions, the approach may be exploited in the synthesis of 
alternative heterocycles including pyrrolidines24,28 (e.g. 3) and 65 
morpholines29 (e.g. 23 and 24) (Panel C).  The approach is likely 
to be most valuable when at least one nitrogen atom can be 
subsequently decorated (either directly, or after removal of a 
protecting group e.g. PMP or Boc). 
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Scheme 4 Control of the position of arylation in the formation of 
octahydrocyclopenta[b]pyrroles.  aligand = 2-diphenylphosphino-2'-(N,N-
dimethylamino)biphenyl. 
Remarkably, the regioselectivity of arylation could be controlled 5 
in cyclisations of substrates such as 25 and 28 (Scheme 4).30  
Crucially, careful choice of ligand controlled the position of the 
introduced substituent (e.g.  27 or 29) for many different aryl 
groups.  In the case of 29, migration of the palladium must occur 
before reductive elimination to give the product.   10 
 
 
Scheme 5 Application of aminoalkynylation and related reactions in the 
synthesis of heterocyclic scaffolds.  Panel A: Illustrative example of the 
approach.  Panel B: Examples of other heterocycles that may be prepared 15 
using the approach.  Panel C: Illustrative examples of products of a 
related Cu-catalysed cyclisation of alkynyl amines.  Panel D: Exploitation 
of the alkyne functionality in a product scaffold as a handle for further 
functionalisation. 
A valuable cyclisation reaction has been exploited in the 20 
synthesis of a range of heterocyclic scaffolds (Scheme 5).31  Pd-
catalysed cyclisation of unsaturated amine derivatives (e.g. 30) 
could be followed by reaction with a terminal alkyne building 
block (e.g.  32) (Panel A).  The approach could be extended to 
yield related scaffolds through cyclisation of alcohol ( 33) or 25 
N-sulfonyl amide ( 34 or 35) nucleophiles (Panel B).  In 
addition, a related Cu-catalysed cyclisation reaction of alkynyl 
amines has been exploited in the synthesis of related scaffolds 
(e.g. 36-38) (Panel C).32  The alkyne substituent in the product 
has been shown to be a useful handle for further functionalisation 30 
(e.g. 39 + 40  41; Panel D).  The exploitation of the approach in 
the synthesis of lead-like scaffolds would require the judicious 
selection of appropriately polar and functionalised building 
blocks. 
 35 
A range of other reactions between bi- and uni-connective 
building blocks have been developed that may be exploited in the 
synthesis of lead-like scaffolds: for example, Pd-catalysed 
aminoacetoxylation.33  In many cases, variation of both building 
blocks has not been exemplified.   40 
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Approaches involving two bi-connective building blocks  
Reactions between pairs of bifunctional building blocks can be 
extremely valuable in lead-oriented synthesis, particularly if 
variation of molecular scaffold is possible.  Such transformations 
have previously been dubbed ambiphile pairing reactions.23  For 5 
example, ring-opening of epoxides (e.g. 43) with unsaturated 
sulfonamides (e.g. 42) could be followed by oxa-Michael 
cyclisation to give the corresponding seven membered sultams 
(e.g. 44) (Scheme 6). 
 10 
Scheme 6 Reaction between two bi-connective building blocks to yield a 
cyclic sultam scaffold. 
Rh-catalysed Michael additions of o-substituted boronic acid 
derivatives have been exploited in the synthesis of a range of 
heterocycles (Scheme 7). For example, 2-aminophenyl boronic 15 
acids (e.g. 45) were reacted with a range of -unsaturated 
ketones (e.g. 46); subsequent cyclisation, and oxidation, yielded 
the corresponding quinolines (e.g. 47).34 It was possible to vary 
the scaffold prepared by varying the chemistry exploited in the 
cyclisation step: for example, Rh-catalysed addition of the 2-20 
aminophenyl boronate ester 48 to an -unsaturated ester 49 
yielded the corresponding tetrahydroquinolinone 50.35 It is 
envisaged that the approach may be extended to the synthesis of 
other heterocyclic scaffolds through further variation of the 
electrophile and the o-substituted phenylboronic acid derivative 25 
used. 
 
Scheme 7 Exploitation of Rh-catalysed conjugate addition reactions in 
the synthesis of heterocyclic scaffolds. 
A range of benzo-fused medium lactam scaffolds have been 30 
prepared by Cu-catalysed amination, followed by ring expansion 
(Scheme 8).36  For example, Cu-catalysed coupling of the aryl 
bromide 51 and the -lactam 52 ( 53) was followed by ring 
expansion to give the medium ring lactam 54 (Panel A).  
Variation of the building blocks enabled the synthesis of related 35 
scaffolds, often with minor modification of the reaction 
conditions used. 
 
Scheme 8 Synthesis of medium lactams by Cu-catalysed amination, and 
transamidation.  Panel A: Illustrative example of the approach.  Panel B: 40 
Examples of other lactams that have been prepared using a broadly 
similar approach. 
The reactions of cyclic sulfamidates with enolates have enabled 
the synthesis of a range of spirocyclic scaffolds (Scheme 9).37  
For example, enolisation of 58, by treatment with LiHMDS, and 45 
reaction with Boc2O yielded a stabilised enolate that was 
subsequently reacted with the cyclic sulfamidate 59 ( 61) 
(Panels A and B).  In this example, we have not considered 
Boc2O to be a building block because it cannot be varied to yield 
alternative scaffolds.  Removal of the Cbz group triggered 50 
spirocyclisation ( 62); reduction gave the scaffold 60.  The 
approach was highly flexible, and a range of scaffolds could be 
prepared by varying the building blocks used: for example, it was 
possible to vary the ring size of both rings in the spirocycle (e.g. 
63 and 64), and to prepare benzo-fused scaffolds (e.g. 65) (Panel 55 
C).  In addition, cyclic sulfamidates are generally easily prepared 
from amino alcohols, which may allow extension to substituted 
analogues of these scaffolds. 
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Scheme 9 Synthesis of spirocyclic scaffolds by ring-opening of cyclic 
sulfamidates with enolates, and subsequent cyclisation.  Panel A: 
Overview of the approach illustrated by a specific example.  Panel B: 
Illustrative synthesis of a spirocyclic scaffold. Panel C: Examples of other 5 
spirocyclic scaffolds that have been prepared using a broadly similar 
approach. 
More complex approaches exploiting pairs of building blocks 
Scaffolds with more complex topologies may be prepared by 
exploiting tri-connective building blocks.  For example, the Ir-10 
catalysed amination reaction between cumyl amine (67) and the 
bis-allylic trichloroacetimidate 66 gave the corresponding 
morpholine 68 with moderate diastereoselectivity in favour of the 
cis diasteroisomer (Panel A, Scheme 10).38  The cis-disubstituted 
substrate 68 underwent a remarkable ring-closing metathesis 15 
reaction to give the bridged bicyclic scaffold 69.  The related 
scaffolds 70 and 71 have been prepared using an analogous 
approach (Panel B).  In this reaction sequence, the exploitation of 
a tri-connective building block (66) enabled the synthesis of a 
bridged scaffold from a pair of building blocks.  20 
 
Scheme 10 Synthesis of bridged scaffolds by Ir-catalysed allylic 
amination, and ring-closing metathesis.  Panel A: Illustrative example of 
the approach.  Panel B: Examples of other scaffolds that have been 
prepared using an analogous approach.  R = cumyl.  25 
 
A Pd-catalysed aminoarylation reaction was exploited in the 
synthesis of bridged scaffolds such as 75 (Scheme 11).39  The 
approach exploited two tri-connective building blocks – 72 and 
73 – which were reacted together to give pentenamine derivatives 30 
such as 74 (Panel A).  Subsequent Pd-catalysed aminoarylation 
(in which the amine, the alkene and the heteroaryl bromide are all 
in the same molecule) gave the bridged scaffold 75.  The 
approach was also exploited in the synthesis of alternative 
bridged scaffolds (including 76, 77 and 78) (Panel B).  The 35 
overall approach illustrates the value of tri-connective building 
blocks in the synthesis of scaffolds with more complex 
topologies. 
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Scheme 11 Synthesis of bridged scaffolds by Pd-catalysed 
aminoarylation.  Panel A: Illustrative example of the approach.  Panel B: 
Examples of other scaffolds that have been prepared. 
 5 
 
Scheme 12 Synthesis of tri- and tetracyclic scaffolds using a Au-
catalysed cascade reaction.  Panel A: Illustrative example of the approach.  
Panel B: Examples of related scaffolds that have also been prepared. 
 10 
A one-pot Au-catalysed cascade has been exploited in the 
preparation of skeletally-diverse alkaloid-like small molecules 
(Scheme 12).40 Initially, Au-catalysed cyclisation of alkynyl 
carboxylic acids (e.g. 79) gave cyclic enol ethers (e.g. 81) which 
underwent attack by amine nucleophiles (e.g. 80) to give 15 
ketoamides (e.g. 82) (Panel A). Under the same reaction 
conditions, the ketoamide intermediate (e.g. 82) was then 
converted into an N-acyl iminium ion (e.g. 83), which was 
trapped by a tethered nucleophile (e.g.  84). The approach has 
been exploited in the synthesis of a range of alkaloid-like 20 
scaffolds (e.g. 85 and 86) by varying the combination of alkynyl 
carboxylic acid and heterocycle-tethered amine used (Panel B).  
Extension to three or more building blocks 
The power of approaches to small molecule scaffolds is greatly 
increased when more than two building blocks are used.  For 25 
example, three bi-connective building blocks – the aldehyde 87, 
the enol ether 88, and the methoxycarbonyl-substituted nitro 
compound 89 – were exploited in the synthesis of the 
phosphodiesterase (PDE) IVb inhibitor 90 (Scheme 13).41  
Initially, the aldehyde 87 and the nitro compound 89 were 30 
condensed to yield the -unsaturated nitro compound 91.  The 
nitroalkene 91 underwent efficient cycloaddition with the chiral 
enol ether 88a to give the nitronate 92 with good 
diastereoselectivity.  Finally, hydrogenation of 92 triggered 
reductive amination and amide formation to yield the bicyclic 35 
lactam 90.  It is likely that this synthetic approach could be 
extended to a range of related scaffolds with alternative 
substitution patterns. 
 
Scheme 13 Synthesis of the PDE IVb inhibitor 90.  Panel A: Overview of 40 
the synthesis of 90.  Panel B: Specific reactions exploited in the synthesis 
of 90. 
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Scheme 14 A multicomponent approach to morpholine derivatives.  Panel 
A: Illustration of the approach in the synthesis of the spirocyclic scaffold 
97.  Panel B: Examples of related scaffolds that have also been prepared 
using the approach. 5 
 
A multicomponent approach to morpholine derivatives that 
exploits three bi-connective building blocks is shown in Scheme 
14.42  Initially, treatment with NBS triggered the reaction 
between an alkene (e.g. 93), an epoxide (e.g. 95) and a 10 
sulfonamide (e.g. 94) ( 96) (Panel A).  Subsequent base-
catalysed cyclisation yielded a morpholine derivative (e.g. 97).  
The approach has also been exploited in the synthesis of more 
lead-like scaffolds in which the spiro-fused ring is heterocyclic 
(as in 98) or substituted (as in 99).  In each case, the scaffolds are 15 
ripe for functionalisation, for example by substitution of chloride 
and/or after removal of the nitrophenylsulfonyl (Ns) protecting 
group. 
 
A three-component reaction has been exploited in the synthesis of 20 
densely-functionalised pyrrolidinones (Scheme 15):43 in this 
reaction, the three components were a (tri-connective) nitro 
acrylate (e.g. 100), a (bi-connective) imine (e.g. 101) and a (uni-
connective) dialkylzinc reagent (e.g. 102) (Panel A).  Initially, 
conjugate addition of the dialkylzinc reagent yielded a nitro anion 25 
(e.g. 104) which underwent a nitro-Mannich reaction with the 
imine (e.g. 101) ( 105); finally, lactamisation yielded a 
pyrrolidinone scaffold (e.g. 103).  The approach has been 
exploited in the synthesis of a range of alternatively-substituted 
pyrrolidinones 106-108 (Panel C), and a related two-component 30 
process has yielded benzo-fused tricyclic scaffolds (e.g. 109 and 
110) (Panel D).44   
 
Scheme 15 Synthesis of pyrrolidinones by a conjugate additionnitro-
Mannichlactamisation cascade. Panel A: Overview of the approach. 35 
Panel B: Illustrative synthesis of a specific scaffold. Panel C: Examples of 
analogues that have been prepared using the approach. Panel D: Examples 
of scaffolds that may be prepared using a related two-component process 
exploiting cyclic imines.  
 40 
The power of approaches to small molecule scaffolds further 
increases with the connectivity of the building blocks used.  A 
synthesis of substituted oxabispidine scaffolds (Scheme 16) 
exploits two tri-connective building blocks – an amine-
substituted epoxide (e.g. 8) and an amino-substituted acetal (e.g. 45 
7) – and one bi-connective building block – an aldehyde (e.g. 9) 
(Panel A).25  Initially, the two tri-connective building blocks were 
condensed to give, after protecting group manipulation, an 
oxazine (e.g. 10); subsequent condensation with an aldehyde (e.g. 
9) enabled formation of a bridged bicyclic scaffold which could 50 
be trapped either an -methoxy amine (as in 111) or as a 
benzotriazole adduct (not shown) (Panel B).   The approach was 
exploited in the synthesis of a range of substituted bispidines such 
as 113 and 114 (Panel C).  It is possible that additional 
substituents might be introduced by substitution (rather than 55 
simple reduction) of the intermediate -methoxy amine (e.g. 111) 
or benzotriazole adduct. 
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Scheme 16 Synthesis of bridged tricyclic oxabispidine scaffolds. Panel A: 
Overview of the approach. Panel B: Illustrative synthesis of a specific 
scaffold. Panel C: Examples of related scaffolds that have been prepared 
using the approach.  5 
Approaches in which the connectivity of building blocks may 
be varied 
The approaches that have thus far been highlighted in this article 
have not allowed wide variation of the connectivity of the 
building blocks used.  However, approaches that do allow the 10 
connectivity of building blocks to be varied – crucially, whilst 
maintaining a common approach – are particularly valuable in the 
synthesis of many diverse molecular scaffolds. 
 
Multicomponent reactions can enable highly efficient synthesis of 15 
diverse molecular scaffolds.45,46  A three-component reaction 
between an amino acid (e.g. 115), an aldehyde derivative (e.g. 
116) and an isocyanide (e.g. 117) has been exploited in the 
synthesis of heterocyclic scaffolds (such as 119) (Scheme 17).47,48  
Iminium ion formation, and attack of the isocyanide yielded a 20 
nitrilium ion which was intercepted (intramolecularly) by the 
carboxylic acid ( 118); subsequent rearrangement yielded the 
scaffold 119 (Panel A).  By varying the amino acid used – i.e. 
using either an acyclic or a different cyclic amino acid – 
alternative scaffolds (e.g. 120 and 121) could be prepared (Panel 25 
B).  The overall approach is highly general because many 
alternative scaffolds are accessible through variation of the 
tethering strategy used.  The scaffolds 119-121 were accessible 
by tethering the amine and the carboxylic acid (i.e. by using an 
amino acid building block).  However, by tethering different 30 
nucleophiles to the amine component (e.g.  122) or the 
carboxylic acid component (e.g.  123), alternative scaffolds are 
accessible (Panel C).49,50  
 
Scheme 17 Application of multicomponent reactions in the synthesis of 35 
diverse scaffolds. Panel A: Overview of a three component reaction 
involving an amino acid, an aldehyde derivative and an isocyanide. Panel 
B: Examples of scaffolds that have also been prepared using the approach. 
Panel C: Scaffolds that have been prepared using related four component 
reactions.  40 
 
Scheme 18 Illustrative examples of diverse scaffolds accessible using a 
branching pathway. Reagents: (a) (i) NH3, NaBH4, Ti(OEt)4, EtOH; (ii) 
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AcOH; (b) (i) NH2OH·HCl, NaOAc, MeCN; (ii) toluene, 140 °C; (c) (i) 
NH2OH·HCl, NaOAc, MeOHMeCN, 60 °C; (ii) NaOEt, EtOH.  
 
Scheme 19 Illustrative syntheses of natural product-like molecules with 
unprecedented scaffold diversity using metathesis cascade chemistry.  5 
The power of the approach lay in the ability to vary the connectivity of 
the building blocks exploited.  RF is a fluorous-tagged substituent. 
Two-directional synthetic approaches have been exploited in the 
synthesis of diverse molecular scaffolds.  The ketone 126, 
prepared by cross-metathesis of the unsaturated ketone 124 and 10 
ethyl acrylate, has been exploited as the key intermediate in a 
branching pathway leading to twelve natural product-like 
scaffolds (Scheme 18).51  Thus, reductive amination could be 
followed by double conjugate addition to give the alkaloid-like 
scaffold 127; in this reaction, 124 functions as a penta-connective 15 
building block.  The approach may be extended to related 
bicyclic scaffolds by using unsymmetrical substrates.52  
Alternatively, oxime formation from 126, and conjugate addition, 
enabled the formation of a nitrone which could undergo 
intramolecular dipolar cycloaddition; alternative scaffolds could 20 
be prepared by exploiting either kinetic control (not shown) or 
thermodynamic control (128).  Furthermore, fragmentation of one 
of these products enabled the preparation of the tricyclic scaffold 
129. 
 25 
An approach to natural product-like molecules of unprecedented 
scaffold diversity (over 80 distinct scaffolds) has been developed 
(Scheme 19).53  The approach relied on the iterative attachment of 
building blocks (shown in green and red) to a fluorous-tagged 
linker (shown in blue) using either permanent or temporary 30 
linkages to yield metathesis substrates (e.g. 130, 132, 134 and 
136).  Metathesis cascade reactions were then used to 
‘reprogramme’ the molecular scaffolds to give, after, 
deprotection, skeletally-diverse products (e.g. 131, 133, 135 and 
137).  The connectivity of the building blocks could be varied by 35 
exploiting both permanent and temporary linkages, and, by 
exploiting some building blocks for which intra-building block 
metathesis reaction was possible. 
Conclusions 
In this Feature Article, we have described a comprehensive 40 
conceptual framework that may be used to capture, analyse and 
plan synthetic approaches to diverse molecular scaffolds.  A wide 
range of synthetic approaches that target, or have potential to 
target, lead-like chemical space were organised using the 
conceptual framework.   Particular emphasis was placed on 45 
synthetic approaches that enable the combinatorial variation of 
molecular scaffold, particularly within lead-like chemical space.   
Table 2 Relative power of synthetic approaches to molecular scaffolds 
Building blocks 
 
Power of approach 
 
Number 
  
Connectivity  Generality Increase in complexity 
2 bi/uni or bi/bi Often high Low 
2 1 building block with      
tri or higher connectivity 
Usually low High 
3 Many combinations of 
building block  
High in 
some cases 
High 
                    connectivities possible 
 50 
The framework is hierarchical, and can thus allow easy 
comparison of the relative power of dissimilar synthetic 
approaches.  Specifically, the ability of approaches to increase 
molecular complexity – from starting building blocks to product 
scaffolds – is captured (Table 2).   55 
 
There are many examples of synthetic approaches that exploit a 
pair of building blocks with low connectivity (bi/uni or bi/bi 
processes).  In many cases, wide variation of the product scaffold 
is possible, for example by using either cyclic or acyclic building 60 
blocks, or by varying the distance between the reactive functional 
groups.  However, the increase in molecular complexity – from 
building blocks to scaffolds – is inherently relatively low.   
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More powerful synthetic approaches are possible if the 
connectivity of the building blocks, or the number of building 
blocks exploited, is increased.  For example, complex scaffolds 
are accessible if at least one of a pair of building blocks has 
higher (i.e. tri or higher) connectivity.  Such approaches can 5 
allow more complex scaffolds to be prepared (such as bridged 
scaffolds), but the preparation of many different scaffolds using a 
single approach has rarely been exemplified (for a rare example, 
see Scheme 11).   
 10 
Synthetic approaches that exploit more than two building blocks 
can sometimes be general – yielding many different scaffolds – 
and also increase molecular complexity greatly: for example, an 
approach exploiting three bi-connective building blocks has 
yielded a wide range of macrocyclic and medium ring scaffolds.54  15 
However, as the connectivity of the building blocks is increased, 
generality is usually compromised. 
 
The connectivity of building blocks can sometimes be varied 
using a common synthetic approach; such approaches are 20 
remarkably powerful and general.  The Ugi reaction, for example, 
has been exploited in the synthesis of an extremely wide range of 
scaffolds by tethering different reacting functional groups (for 
some examples, see Scheme 17).   A synthesis of natural products 
of unprecedented scaffold diversity (>80 scaffolds) was possible 25 
because variation of the linkages between building blocks, and 
the connectivity of the building blocks, was possible (see Scheme 
19).   
 
Syntheses of diverse molecular scaffolds are still, however, 30 
dominated by a small number of highly general reactions, most 
notably alkene metathesis and the Ugi reaction.  A major 
challenge for synthetic chemists is, therefore, to develop 
powerful, yet general, synthetic approaches to lead-like molecular 
scaffolds.  Such approaches will help to address the uneven 35 
exploration of chemical space by synthesis, and may yield 
valuable starting points for drug discovery programmes. 
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